How Protein-Rich Plasma Works
Protein-rich plasma (PRP) works by delivering supraphysiological concentrations of platelets that release growth factors and bioactive proteins from their α-granules upon activation, creating a regenerative microenvironment that promotes angiogenesis, cell migration, proliferation, and tissue repair through a fibrin scaffold matrix. 1
Core Mechanism of Action
PRP functions through a multi-step biological cascade:
Platelet Activation and Growth Factor Release
When PRP is activated (typically through thrombin or re-calcification), platelets degranulate and release their α-granule contents into the local tissue environment 1. These α-granules contain a vast array of critical growth factors including:
- Platelet-derived growth factor (PDGF)
- Insulin-like growth factor (IGF)
- Vascular endothelial growth factor (VEGF)
- Transforming growth factor beta-1 (TGF-β1)
These growth factors collectively promote local angiogenesis, stem cell homing, cell migration, proliferation, and differentiation, coupled with deposition of matrix proteins like collagen 2.
Fibrin Scaffold Formation
Beyond growth factor delivery, PRP creates a fibrin scaffold at the application site that acts as a temporary matrix to assist repair of injured tissue 1. This scaffold serves dual purposes:
- Captures and maintains secreted proteins at the application site
- Provides structural support for invading resident cells (macrophages, fibroblasts, mesenchymal stem cells) 3
The scaffold undergoes gradual fibrinolysis, leading to sustained release of concentrated cells and molecules retained in the matrix until dissolution 3.
Additional Cellular Components
Leukocyte Contribution
The presence of leukocytes in PRP preparations significantly impacts biological activity beyond simple platelet effects 1. Leukocytes contribute through:
- Immune and antibacterial properties
- Key roles in tissue healing and local growth factor regulation 1
- Anti-inflammatory effects: PRP promotes macrophage polarization from pro-inflammatory M1 phenotype to anti-inflammatory M2 phenotype 2
- Anti-nociceptive effects: Leukocytes release anti-inflammatory cytokines, chemokines, and opioid peptides that reduce pain 2
Plasma Protein Enrichment
Modern protein-rich PRP formulations concentrate not just platelets but also plasma proteins through ultrafiltration 3. This creates higher concentrations of:
- Fibrinogen (for scaffold formation)
- Albumin
- Alpha-2-macroglobulin
- Extraplatelet growth factors (IGF-1, HGF) that reside outside platelet granules 3, 4
These extraplatelet molecules are particularly important as they inhibit inflammation and fibrosis while promoting keratinocyte migration 3.
Cellular-Level Effects
At the tissue level, PRP influences multiple fundamental processes:
Inflammation Modulation
- Suppresses nuclear factor-κβ and PI3K/AKT signaling pathways 5
- Reduces pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) 6
- Modulates oxidative stress in affected tissues 5
Proliferation and Migration
- Enhances cell viability in fibroblasts and chondrocytes 4
- Stimulates proliferative phases of healing 7
- Promotes chondrogenesis and angiogenesis 5
Tissue Remodeling
- Enhances remodeling phases through sustained growth factor release 7
- Restores normal tissue structure and function through collagen deposition 1
Critical Preparation Variables
Important caveat: The biological activity of PRP varies dramatically based on preparation methods 1. Key variables affecting efficacy include:
- Centrifugation parameters (g-force, duration): Different protocols yield different platelet concentrations, purity, and activation status
- Anticoagulant choice: Trisodium citrate preferred; EDTA causes unwanted platelet activation 1
- Activation method: Thrombin vs. re-calcification affects release kinetics
- Leukocyte content: Leukocyte-rich vs. pure PRP have different biological properties 1
This lack of standardization explains why clinical trials show varying efficacies—the "PRP" being tested may have fundamentally different biological properties depending on preparation 1.
Extracellular Vesicle Component
Newer evidence demonstrates that PRP contains extracellular vesicles (EVs) that facilitate cell-cell communication and signaling 3. Protein-rich formulations show significantly higher EV concentrations, adding another layer to PRP's regenerative mechanism beyond traditional growth factor release 6.